These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1285 related items for PubMed ID: 11322784

  • 1. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H, Jezequel S, Löhr M, Shaikh S, Davis D, Soker S, Selwood D, Zachary I.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):164-73. PubMed ID: 11322784
    [Abstract] [Full Text] [Related]

  • 2. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
    Jia H, Lohr M, Jezequel S, Davis D, Shaikh S, Selwood D, Zachary I.
    Biochem Biophys Res Commun; 2001 May 04; 283(2):469-79. PubMed ID: 11327725
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec 04; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 4. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J.
    Mol Cancer Res; 2002 Nov 04; 1(1):2-11. PubMed ID: 12496364
    [Abstract] [Full Text] [Related]

  • 5. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 6. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pépin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.
    Clin Cancer Res; 2002 Apr 01; 8(4):1242-50. PubMed ID: 11948139
    [Abstract] [Full Text] [Related]

  • 7. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 01; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 8. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F.
    Cancer Res; 2000 Apr 15; 60(8):2178-89. PubMed ID: 10786682
    [Abstract] [Full Text] [Related]

  • 9. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action.
    Waltenberger J, Mayr U, Frank H, Hombach V.
    J Mol Cell Cardiol; 1996 Jul 15; 28(7):1523-9. PubMed ID: 8841939
    [Abstract] [Full Text] [Related]

  • 10. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells.
    Yang SP, Morita I, Murota SI.
    J Cell Physiol; 1998 Aug 15; 176(2):342-9. PubMed ID: 9648921
    [Abstract] [Full Text] [Related]

  • 11. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
    Kranz A, Mayr U, Frank H, Waltenberger J.
    Lab Invest; 1999 Aug 15; 79(8):985-91. PubMed ID: 10462036
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000 Aug 15; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
    Grosskreutz CL, Anand-Apte B, Dupláa C, Quinn TP, Terman BI, Zetter B, D'Amore PA.
    Microvasc Res; 1999 Sep 15; 58(2):128-36. PubMed ID: 10458928
    [Abstract] [Full Text] [Related]

  • 14. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C.
    EMBO J; 1999 Jan 15; 18(2):363-74. PubMed ID: 9889193
    [Abstract] [Full Text] [Related]

  • 15. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B, Li B, Russell SJ, Tom JY, Cochran AG, Fairbrother WJ.
    J Mol Biol; 2002 Feb 22; 316(3):769-87. PubMed ID: 11866530
    [Abstract] [Full Text] [Related]

  • 16. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH, Claesson-Welsh L.
    Exp Cell Res; 2001 Feb 01; 263(1):173-82. PubMed ID: 11161716
    [Abstract] [Full Text] [Related]

  • 17. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
    Kroll J, Waltenberger J.
    Biochem Biophys Res Commun; 1999 Nov 30; 265(3):636-9. PubMed ID: 10600473
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S, Olson TA, Bautch VL, Mohanraj D.
    Cancer Res; 1996 Mar 15; 56(6):1324-30. PubMed ID: 8640821
    [Abstract] [Full Text] [Related]

  • 19. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.
    Cancer Res; 2002 Dec 01; 62(23):6884-90. PubMed ID: 12460903
    [Abstract] [Full Text] [Related]

  • 20. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J, Morita I, Onodera M, Murota SI.
    J Cell Physiol; 2002 Feb 01; 190(2):238-50. PubMed ID: 11807828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.